Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 52 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

9 trials in Phase 3/4

Results Transparency

11%

2 of 19 completed trials have results

Key Signals

4 recruiting2 with results

Enrollment Performance

Analytics

N/A

9(40.9%)

Phase 4

9(40.9%)

Phase 2

2(9.1%)

Phase 1

2(9.1%)

22Total

N/A(9)

Phase 4(9)

Phase 2(2)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (52)

Showing 20 of 52 trials

NCT07508969Phase 1Completed

Proprioceptive Neuromuscular Facilitation vs Conventional Therapy With Ultrasound-Guided Corticosteroid Injections for Subacromial Bursitis

Role: lead

NCT07504432Phase 1Completed

Efficacy of Oxygen-ozone Therapy and Cervical Rehabilitation

Role: lead

NCT07312968Active Not Recruiting

AI4Triage - Development of an Artificial Intelligence Based Methods for the Analysis of Triage Data.

Role: lead

NCT06844552Recruiting

Diamagnetic Therapy in Pain and Inflammation

Role: lead

NCT06814769Completed

Hyaluronic Acid and Articular Pain

Role: lead

NCT06790381Not Yet Recruiting

Effect of Biological Sex on Multimodal Biomarkers of Disease Progression in Patients with Parkinson's Disease

Role: collaborator

NCT06551974Not ApplicableRecruiting

INTERconNEcT-Eds: a Guided Self-help Mobile App to Improve Outcome in Eating Disorders

Role: collaborator

NCT06540820Not Yet Recruiting

NEUROENDOCRINE REGULATION OF BONE-FAT CROSSTALK IN OBESITY

Role: collaborator

NCT05988333Not ApplicableRecruiting

Psychoeducational Intervention for Families With a Member Affected by Major Depression

Role: collaborator

NCT05686707Recruiting

Characterization of Different Phenotypes of Microvascular Dysfunction and Their Impact on Angina Severity in Patients With Chronic Angina in the Absence of Obstructive Coronary Artery Disease.

Role: collaborator

NCT05915364Unknown

MAgna GraecIa Evaluation of Comorbidities in Patients With Heart Failure STUDY

Role: lead

NCT05749471Unknown

Sex Dysfunction and Chronic Venous Disease

Role: lead

NCT04183868Phase 4Completed

Effects of empagliFlozin on myocardIal metabOlic Rate of glucosE Estimated Through 18FDG PET (FIORE Study)

Role: lead

NCT04654104Unknown

Immune Checkpoints in COPD

Role: lead

NCT05509075Unknown

Nutraceuticals and Functional Foods

Role: lead

NCT05472480Unknown

Anthropometric and Psychosocial Measurements in Vascular Disease

Role: lead

NCT05134597Unknown

Gene Expression in Chronic Venous Leg Ulcers

Role: lead

NCT04322513Unknown

Biomarkers for Identification of COVID-19 Infection

Role: lead

NCT04710186Unknown

AR, IGF-IR, IR and Peripheral Artery Disease

Role: lead

NCT04567212Unknown

Gender Differences and SNPs in Asthmatic Patients

Role: lead